FDA Approves Nivolumab With Chemotherapy For Previously Untreated Hodgkin Lymphoma

March 20 (Reuters) - FDA:

• FDA APPROVES NIVOLUMAB WITH CHEMOTHERAPY FOR PREVIOUSLY UNTREATED HODGKIN LYMPHOMA

• FDA: GRANTED TRADITIONAL APPROVAL TO NIVOLUMAB FOR ADULTS WITH RELAPSED OR REFRACTORY CHL AFTER AUTOLOGOUS HSCT & BRENTUXIMAB VEDOTIN

• FDA:GRANTED TRADITIONAL APPROVAL TO NIVOLUMAB FOR ADULTS WITH RELAPSED/REFRACTORY CHL AFTER 3/MORE LINES OF SYSTEMIC THERAPY INCLUDING AUTOLOGOUS HSCT